CalciMedica CALC
NASDAQ CALC
$1.07 +0.05 (+4.41%)
At close: Oct 20, 2026 · 4:00 PM EDT

CalciMedica (CALC) EBITDA Margin (2024)

Updated

CalciMedica's EBITDA Margin came in at -2877.57% for Q4 2024, down 252.80 percentage points from the prior quarter.

Analysis

CalciMedica (CALC) EBITDA Margin (2024) Analysis & Trends

For FY2024, CalciMedica's EBITDA Margin was -2381.26%.

  • Business Quant data shows CALC's EBITDA Margin at -2624.77% (Q3 2024), -2368.73% (Q2 2024) and -1873.62% (Q1 2024) in the three quarters before Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 35.95%
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 49.01%
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 6.02%
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 33.11%
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 46.01%
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -124.26%
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 39.16%
10 CalciMedica 3.63 Mn -14.97 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -2,877.57%
Sep 30, 2024 -2,624.77%
Jun 30, 2024 -2,368.73%
Mar 31, 2024 -1,873.62%
API Access

CalciMedica EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CALC&period=max&api_key=YOUR_API_KEY